| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 1137 |
| 1 | UPADACITINIB | 1047 |
| 2 | ETANERCEPT | 768 |
| 3 | RISANKIZUMAB-RZAA | 651 |
| 4 | GABAPENTIN | 628 |
| 5 | TOFACITINIB | 556 |
| 6 | DUPILUMAB | 471 |
| 7 | ERGOCALCIFEROL | 470 |
| 8 | PREDNISONE | 426 |
| 9 | OXYCODONE HYDROCHLORIDE | 403 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE | 77 | 0.0216 |
| 1 | CHLORPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HCL | 3 | 0.0133 |
| 2 | UPADACITINIB | 1047 | 0.0129 |
| 3 | PENCICLOVIR | 4 | 0.0111 |
| 4 | ATROPINE INJECTION, 2 MG | 16 | 0.0108 |
| 5 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 4 | 0.0083 |
| 6 | RISANKIZUMAB-RZAA | 651 | 0.0080 |
| 7 | VUTRISIRAN | 20 | 0.0079 |
| 8 | CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES | 67 | 0.0078 |
| 9 | OXYMORPHONE HYDROCHLORIDE | 79 | 0.0068 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 1109 |
| 1 | Janus Kinase Inhibitor [EPC] | 1069 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 936 |
| 3 | Interleukin-23 Antagonist [EPC] | 755 |
| 4 | Corticosteroid [EPC] | 658 |
| 5 | Benzodiazepine [EPC] | 554 |
| 6 | Interleukin-4 Receptor alpha Antagonist [EPC] | 471 |
| 7 | Provitamin D2 Compound [EPC] | 470 |
| 8 | Proton Pump Inhibitor [EPC] | 415 |
| 9 | Vitamin C [EPC] | 407 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Janus Kinase Inhibitor [EPC] | 1069 | 0.0064 |
| 1 | Sucrose-specific Enzyme [EPC] | 1 | 0.0060 |
| 2 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 39 | 0.0059 |
| 3 | Neonatal Fc Receptor Blocker [EPC] | 27 | 0.0051 |
| 4 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 18 | 0.0048 |
| 5 | Antidiarrheal [EPC] | 1 | 0.0043 |
| 6 | Muscle Relaxant [EPC] | 194 | 0.0043 |
| 7 | Medium-chain Triglyceride [EPC] | 2 | 0.0038 |
| 8 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 47 | 0.0036 |
| 9 | Interleukin-23 Antagonist [EPC] | 755 | 0.0034 |